Access cutting-edge cidp treatment through this clinical trial at a research site in Glenview. Study-provided care at no cost to qualified participants.
Access cidp specialists in Glenview at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cidp treatment provided free
The purpose of the study is to evaluate efficacy of riliprubart compared to placebo in adult participants with CIDP whose disease is refractory to standard of care. The study duration will be for a maximum of 111 weeks including screening, treatment phases, and follow-up.
Sponsor: Sanofi
Check if you qualify for this cidp clinical trial in Glenview, IL
If you're searching for cidp treatment options in Glenview, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Glenview research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cidp specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.